user

Ablative treatment with 131I in low-risk papillary thyroid cancer: is low-dose as effective as high-dose?

被引：0
|
作者：
Unceta Barrenechea, A. Roteta [1 ,2 ]
Andres Gracia, A. [1 ,2 ]
Tardin Cardoso, L. [1 ]
Saker Diffalah, Y. [1 ]
Razola Alba, P. [1 ]
Escalera Temprado, T. [1 ]
Delgado Castro, M. [1 ]
Prats Rivera, E. [1 ]
Abos Olivares, M. [1 ]
机构：
[1] UCMHMNA Clin Hosp Lozano Blesa, Zaragoza, Spain
[2] IIS Aragon, Zaragoza, Spain
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-1033
引用
收藏
页码：S362 / S363
页数：2
相关论文
共 50 条
  • [1] Low-dose and high-dose 131I therapy for low and intermediate risk differentiated thyroid cancer: a randomized controlled clinical study
    瞿源
    ChinaMedicalAbstracts(InternalMedicine), 2017, 34 (01) : 20 - 21
  • [2] Comparison between low and high radioactive iodine (131I) ablation dose in patients with low risk of papillary thyroid cancer
    el Bez, I. G. E.
    Slim, I.
    Ben Ghachem, T.
    Yeddes, I.
    Meddeb, I.
    Zaabar, L.
    Ben Sellem, D.
    Ltaief, B.
    Mhiri, A.
    Ben Slimene, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S732 - S733
  • [3] Role of 131I in low-risk differentiated thyroid cancer
    Vallejo, J. A.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (01): : 33 - 37
  • [4] LOW-DOSE AND HIGH-DOSE RADIOIODINE IN THYROID CANCER - REPLY
    MCCOWEN, KD
    AMERICAN JOURNAL OF MEDICINE, 1977, 63 (01): : 167 - 168
  • [5] Efficacy of Low-Dose I-131 Therapy for the Postoperative Ablation of Low-Risk Differentiated Thyroid Cancer Patients
    Caglar, M.
    Bozkurt, F.
    Kapulu, C.
    Ugur, O.
    Bayraktar, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S344 - S344
  • [6] Comparison between low and high radioactive iodine (131I) reablation dose in patients with papillary thyroid cancer
    El-Refaei, Sherif M.
    Yassin, Shereen W.
    Salman, Khaled
    Al Munshy, Tarek
    Al-Ezzi, Manal
    Al-Sayed, Yasser M.
    Husseni, Maha Abd Elkareem
    NUCLEAR MEDICINE COMMUNICATIONS, 2015, 36 (02) : 114 - 119
  • [7] Is 740 MBq of iodine 131 (131I) an ablative dose for thyroid remnants, after total thyroidectomy for low risk group patients with differentiated thyroid cancer ?
    Cuif-Job, A.
    Fieffe, S.
    Kere, D.
    Wernert, R.
    Pochart, J.
    Schvartz, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S222 - S223
  • [8] Low-Dose Radioiodine Ablation in Patients with Low-Risk Differentiated Thyroid Cancer
    Jimenez Londono, German A.
    Garcia Vicente, Ana Maria
    Sastre Marcos, Julia
    Pena Pardo, Francisco Jose
    Amo-Salas, Mariano
    Moreno Caballero, Manuel
    Talavera Rubio, Maria Prado
    Gonzalez Garcia, Beatriz
    Disotuar Ruiz, Niletys Dafne
    Soriano Castrejon, Angel Maria
    EUROPEAN THYROID JOURNAL, 2018, 7 (04) : 218 - 224
  • [9] Dose reduction of 131i ablative therapy for treatment differentiated thyroid cancer in a hospital setting
    Lima, A.
    Garcia-Burillo, A.
    Soriano, B.
    Quera, M.
    Moga, M.
    Modamio, P.
    Castell, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 986 - 986
  • [10] High-dose low-dose
    deVries, EGE
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 599 - 599
12345